Drug intelligence / Profile preview

glucose + caffeine

Development stage
Preclinical
Lead developer
University of Barcelona
Modality
Small Molecules
Administration
Oral
01

Overview

**Glucose + caffeine** is a combination of two active ingredients, commonly present in beverages such as energy drinks and some pharmaceutical formulations. Glucose serves as a rapid source of metabolic energy for brain and muscle activity, while caffeine acts as a central nervous system stimulant, antagonizing adenosine receptors to promote wakefulness, enhance alertness, and improve cognitive performance. Studies in healthy adults show that the co-administration of glucose and caffeine synergistically enhances cognitive processes, such as sustained attention, working memory, and multi-tasking ability, more effectively than either glucose or caffeine alone[1][2][4]. This combination increases the efficiency of brain activity, evidenced by improved performance in complex cognitive tasks and reduced neural activation in relevant brain regions, indicating greater neural efficiency[2]. These improvements are believed to result from complementary metabolic and neurostimulatory actions: glucose supports energy-demanding cognitive processes, while caffeine increases attentional resources, executive functioning, and processing speed[1][2][4].

Other names
glucose + caffeine
02

Targets

ADORA1 (Adenosine receptor A1 subtype)ADORA2A (Adenosine A₂A Receptor)GABRR (GABA-A receptor subunit rho)PDE (Phosphodiesterase family)

Beyond the preview

Go deeper on glucose + caffeine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on glucose + caffeine.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call